Numeral Lifesciences

Numeral Limited (formerly Go Life International) is a Mauritius-based investment holding company focused on the biotechnology, longevity, and healthcare sectors. The company operates through a vertically integrated model, acquiring and accelerating pioneering businesses in areas such as stem cell therapy, genetic research, and regenerative medicine. Its core assets include Numeral Biotechnologies, which is developing first-in-class senolytic compounds targeting the FOXO4-p53 axis, and Cryo-Save, a major stem cell banking business. Through subsidiaries like Longevity Lab and Celerevive, Numeral offers wellness protocols and cellular optimization treatments aimed at advancing human health and longevity. The company is publicly listed on the Stock Exchange of Mauritius and the Johannesburg Stock Exchange. Numeral continues to expand its portfolio through strategic acquisitions of innovation-driven biotech and medical firms across Africa, Europe, and Asia.